136 related articles for article (PubMed ID: 28203238)
1. Differential Ability of Bovine Antimicrobial Cathelicidins to Mediate Nucleic Acid Sensing by Epithelial Cells.
Baumann A; Kiener MS; Haigh B; Perreten V; Summerfield A
Front Immunol; 2017; 8():59. PubMed ID: 28203238
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum activity against bacterial mastitis pathogens and activation of mammary epithelial cells support a protective role of neutrophil cathelicidins in bovine mastitis.
Tomasinsig L; De Conti G; Skerlavaj B; Piccinini R; Mazzilli M; D'Este F; Tossi A; Zanetti M
Infect Immun; 2010 Apr; 78(4):1781-8. PubMed ID: 20100862
[TBL] [Abstract][Full Text] [Related]
3. Porcine cathelicidins efficiently complex and deliver nucleic acids to plasmacytoid dendritic cells and can thereby mediate bacteria-induced IFN-α responses.
Baumann A; Démoulins T; Python S; Summerfield A
J Immunol; 2014 Jul; 193(1):364-71. PubMed ID: 24899499
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of human and animal cathelicidins against livestock-associated methicillin-resistant Staphylococcus aureus.
Blodkamp S; Kadlec K; Gutsmann T; Naim HY; von Köckritz-Blickwede M; Schwarz S
Vet Microbiol; 2016 Oct; 194():107-111. PubMed ID: 26453316
[TBL] [Abstract][Full Text] [Related]
5. Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils.
Xie F; Zan Y; Zhang X; Zhang H; Jin M; Zhang W; Zhang Y; Liu S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182913
[TBL] [Abstract][Full Text] [Related]
6. Testing cathelicidin susceptibility of bacterial mastitis isolates: Technical challenges and data output for clinical isolates.
Langer MN; Blodkamp S; Bayerbach M; Feßler AT; de Buhr N; Gutsmann T; Kreienbrock L; Schwarz S; von Köckritz-Blickwede M
Vet Microbiol; 2017 Oct; 210():107-115. PubMed ID: 29103679
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a bovine myeloid antimicrobial peptide (BMAP-28) against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Takagi S; Hayashi S; Takahashi K; Isogai H; Bai L; Yoneyama H; Ando T; Ito K; Isogai E
Anim Sci J; 2012 Jun; 83(6):482-6. PubMed ID: 22694332
[TBL] [Abstract][Full Text] [Related]
8. Role of Cathelicidin Peptides in Bovine Host Defense and Healing.
Tomasinsig L; Benincasa M; Scocchi M; Skerlavaj B; Tossi A; Zanetti M; Gennaro R
Probiotics Antimicrob Proteins; 2010 Mar; 2(1):12-20. PubMed ID: 26780897
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide.
Yang S; Lee CW; Kim HJ; Jung HH; Kim JI; Shin SY; Shin SH
Peptides; 2019 Aug; 118():170106. PubMed ID: 31226350
[TBL] [Abstract][Full Text] [Related]
10. Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide.
Sang Y; Teresa Ortega M; Rune K; Xiau W; Zhang G; Soulages JL; Lushington GH; Fang J; Williams TD; Blecha F; Melgarejo T
Dev Comp Immunol; 2007; 31(12):1278-96. PubMed ID: 17462733
[TBL] [Abstract][Full Text] [Related]
11. A bovine myeloid antimicrobial peptide (BMAP-28) kills methicillin-resistant Staphylococcus aureus but promotes adherence of the bacteria.
Takagi S; Bai L; Ozeki T; Miyagi H; Kuroda K; Hayashi S; Yoneyama H; Ando T; Isogai E
Anim Sci J; 2014 Mar; 85(3):342-6. PubMed ID: 23981031
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility difference between methicillin-susceptible and methicillin-resistant Staphylococcus aureus to a bovine myeloid antimicrobial peptide (BMAP-28).
Takagi S; Nishimura J; Bai L; Miyagi H; Kuroda K; Hayashi S; Yoneyama H; Ando T; Isogai H; Isogai E
Anim Sci J; 2014 Feb; 85(2):174-9. PubMed ID: 23905845
[TBL] [Abstract][Full Text] [Related]
13. Biological characterization of a novel mammalian antimicrobial peptide.
Gennaro R; Scocchi M; Merluzzi L; Zanetti M
Biochim Biophys Acta; 1998 Oct; 1425(2):361-8. PubMed ID: 9795251
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca spp.
Tomasinsig L; Skerlavaj B; Scarsini M; Guida F; Piccinini R; Tossi A; Zanetti M
J Pept Sci; 2012 Feb; 18(2):105-13. PubMed ID: 22083804
[TBL] [Abstract][Full Text] [Related]
15. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
Lee EK; Kim YC; Nan YH; Shin SY
Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
[TBL] [Abstract][Full Text] [Related]
16. Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.
Wang G; Watson KM; Buckheit RW
Antimicrob Agents Chemother; 2008 Sep; 52(9):3438-40. PubMed ID: 18591279
[TBL] [Abstract][Full Text] [Related]
17. Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences.
Ahmad A; Asthana N; Azmi S; Srivastava RM; Pandey BK; Yadav V; Ghosh JK
Biochim Biophys Acta; 2009 Nov; 1788(11):2411-20. PubMed ID: 19735644
[TBL] [Abstract][Full Text] [Related]
18. Identification of three novel myeloid cathelicidin cDNAs and their predicted peptides in buffalo (Bubalus bubalis).
Panicker VP; George S
Indian J Biochem Biophys; 2013 Aug; 50(4):273-7. PubMed ID: 24772945
[TBL] [Abstract][Full Text] [Related]
19. Interaction of blood components with cathelicidins and their modified versions.
Yu K; Lai BF; Gani J; Mikut R; Hilpert K; Kizhakkedathu JN
Biomaterials; 2015 Nov; 69():201-11. PubMed ID: 26295533
[TBL] [Abstract][Full Text] [Related]
20. Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity.
Ahmad A; Azmi S; Srivastava RM; Srivastava S; Pandey BK; Saxena R; Bajpai VK; Ghosh JK
Biochemistry; 2009 Nov; 48(46):10905-17. PubMed ID: 19845398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
